67 related articles for article (PubMed ID: 26198031)
21. Promising Antineoplastic Actions of Melatonin.
Favero G; Moretti E; Bonomini F; Reiter RJ; Rodella LF; Rezzani R
Front Pharmacol; 2018; 9():1086. PubMed ID: 30386235
[TBL] [Abstract][Full Text] [Related]
22. Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms.
Chen L; Zhang YH; Zhang Z; Huang T; Cai YD
Mol Ther Methods Clin Dev; 2018 Sep; 10():57-67. PubMed ID: 30069494
[TBL] [Abstract][Full Text] [Related]
23. The protective mechanism of Ginkgolides and Ginkgo flavonoids on the TNF-α induced apoptosis of rat hippocampal neurons and its mechanisms in vitro.
Guo M; Suo Y; Gao Q; Du H; Zeng W; Wang Y; Hu X; Jiang X
Heliyon; 2015 Sep; 1(1):e00020. PubMed ID: 27441214
[TBL] [Abstract][Full Text] [Related]
24. Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
Elmallah MI; Micheau O
Mar Drugs; 2015 Nov; 13(11):6884-909. PubMed ID: 26580630
[TBL] [Abstract][Full Text] [Related]
25. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB; Bhardwaj U; Takada Y
Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190
[TBL] [Abstract][Full Text] [Related]
26. Drugs interfering with apoptosis in breast cancer.
Grimm D; Wehland M; Pietsch J; Infanger M; Bauer J
Curr Pharm Des; 2011; 17(3):272-83. PubMed ID: 21348828
[TBL] [Abstract][Full Text] [Related]
27. TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
Seol JY; Mihich E; Berleth ES
Cytokine; 2015 Oct; 75(2):321-9. PubMed ID: 26198031
[TBL] [Abstract][Full Text] [Related]
28. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
[TBL] [Abstract][Full Text] [Related]
29. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.
Okano H; Shiraki K; Inoue H; Kawakita T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Fujikawa K; Murata K; Nakano T
Lab Invest; 2003 Jul; 83(7):1033-43. PubMed ID: 12861043
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
Kreuz S; Siegmund D; Scheurich P; Wajant H
Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
[TBL] [Abstract][Full Text] [Related]
31. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
[TBL] [Abstract][Full Text] [Related]
33. Role of A20 in cIAP-2 protection against tumor necrosis factor α (TNF-α)-mediated apoptosis in endothelial cells.
Guo S; Messmer-Blust AF; Wu J; Song X; Philbrick MJ; Shie JL; Rana JS; Li J
Int J Mol Sci; 2014 Mar; 15(3):3816-33. PubMed ID: 24595242
[TBL] [Abstract][Full Text] [Related]
34. Soluble calreticulin induces tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 production by macrophages through mitogen-activated protein kinase (MAPK) and NFκB signaling pathways.
Duo CC; Gong FY; He XY; Li YM; Wang J; Zhang JP; Gao XM
Int J Mol Sci; 2014 Feb; 15(2):2916-28. PubMed ID: 24566135
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous golimumab therapy for ulcerative colitis.
Lowe AW; Moseley RH
Gastroenterology; 2014 Jan; 146(1):1-2. PubMed ID: 24501748
[No Abstract] [Full Text] [Related]
36. [Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Novacek G; Dejaco C; Knoflach P; Moschen A; Petritsch W; Vogelsang H; Reinisch W
Z Gastroenterol; 2014 Feb; 52(2):204-11. PubMed ID: 24488763
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
